draft cbm working paper for seventh btwc review …httpassets... · draft cbm working paper for...
TRANSCRIPT
Draft CBM Working Paper
for
Seventh BTWC Review Conference
Opportunities to Enhance the
BWC Confidence Building Measures
Geneva, 15 April 2011
Dr. Volker Beck
Federal Foreign Office
Germany
Sixth Review Conference - Outcome
Revcon 2006, Final Document:
… the Conference reviewed the implementation of
the CBMs during its session and agrees that the issue
merits further and comprehensive attention at the
Seventh Review Conference.
Geneva Forum CBM Process
Three Geneva Forum CBM Workshops in 2009 and 2010
Outcome presentation August 2010 - published by
Filippa Lentzos and Alexander Hamilton:
Preparing for a comprehensive review of the CBM
mechanism at the Seventh BWC Review Conference –
2009-2010 workshop series report*
E-mail platform: approx. 80 participants – gov and
non-gov experts from all three regional groups
► Presentation in Geneva in December 2010
* http://www2.lse.ac.uk/BIOS/research/biosecurity/pdf/Workshop_Report_Lentzos_Hamilton.pdf
Preparing for the BWC Revcon 2011
Beijing Workshop (November 2010)
… two options for the Review Conference: reform the
CBMs, or replace them with something entirely new;
… question of whether to seek agreement on CBMs at
the Review Conference itself, or to commission work
on the issue in the intersessional process, or a
combination of both
Geneva Forum Presentation December 2010
… preparation of a draft CBM Working Paper for
reviewing and updating existing CBMs at the RevCon;
… option for examniation of further CBM proposals
during the intersessional process
Draft CBM Working Paper (1)
A. Introduction
1. Why is a CBM update necessary?
2. Preparing proposals for CBM updates for adoption
at the Seventh BTWC Review Conference
B. Proposals for updating the CBM Forms at the
Seventh Review Conference
CBMs: Proposed Updates
A, part 1 maximum containment laboratories
A, part 2 (i) biodefence programmes – yes/no
A, part 2 (ii) biodefence programmes - programme
A, part 2 (iii) biodefence programmes - facilities
B (i) outbreaks of infectious diseases - statistics
B (ii) outbreaks of infectious diseases - report
C publication of results of research
D active promotion of contacts
E legislation, regulations and other measures
F past offensive/defensive programmes
G vaccine production facilities
0 nothing/nothing new to declare
amend
amend
amend
amend
delete
amend
delete
amend
amend
unchanged
amend
amend
CONFIDENCE-BUILDING MEASURE "A, part 1(i)"
Part 1: Exchange of data on research centres and
laboratories
1. Name(s) of facility
2. Responsible public or private organization or company
3. Location and postal address
4. Source(s) of financing of the reported activity, including indication if the
activity is wholly or partly financed by the Ministry of Defence
5. Number of maximum containment units within the research centre
and/or laboratory, with an indication of their respective size (m2)
6. If no maximum containment unit, indicate highest level of protection
7. 6. Scope and general description of activities, including type(s) of micro-
organisms and/or toxins as appropriate
7. Briefly describe the publication policy of the research centre and/or laboratory
8. Provide a list of publicly-available papers and reports resulting from the
work published during the previous 12 months. (To include authors, titles and full
references.)
CONFIDENCE-BUILDING MEASURE "A, part 1 (ii)"
New:
Given the proposed deletion of item #6 in Form A, part 1(i) a new form could be added for States Parties that do not possess a BSL4 facility:
If no BSL4 laboratory is declared in Form A, part 1(i),
indicate the highest biosafety level implemented in facilities handling biological agents* on the State Party’s territory :
* Microorganisms pathogenic to humans and animals
** In accordance with the WHO Laboratory Biosafety Manual, the OIE Terrestrial Manual or equivalent.
Biosafety level 2** yes / no
Biosafety level 3** yes / no
CONFIDENCE-BUILDING MEASURE "A, part 2"
Now:
Exchange of information on national biological defence
research and development programmes
New:
Exchange of information on national research and
development programmes for protection of humans,
animals or plants against the hostile use of biological
agents and toxins
CONFIDENCE-BUILDING MEASURE "A, part 2 (ii)"
Declaration of programmes
Add new item # 7 to the description of the programme
1. ….
…
6. ….
7. Describe the internal and external oversight
mechanisms for such programmes
7. 8. ….
CONFIDENCE-BUILDING MEASURE „B"
- Delete B(i)
- Amend B(ii) and rename it (B)
Notify links to national websites or websites of international (WHO, OIE) or
other organizations (GOARN, PROMED) that provide information on
outbreaks of infectious diseases and similar occurrences, that seem to
deviate from the normal pattern, or use the following declaration scheme:
1. Time of cognizance of the outbreak ......................................................
2. Location and approximate area affected ...............................................
3. Type of disease/intoxication ..................................................................
…
14. Assistance requested ……. yes/no …
15. Assistance received …… . yes/no …
CONFIDENCE-BUILDING MEASURE „D"
Active promotion of contacts
- Retain this form, but report forward looking events/
activities only.
Form D
1. Planned international conferences, symposia, seminars, and other
similar forums for exchange
2. Information regarding other opportunities , i.e. areas in which
cooperation would be welcomed/could be offered, including
indicating a point of contact or others
CONFIDENCE-BUILDING MEASURE „E“ (1)
Declaration of legislation, regulations and other measures
Relating to Legislation Regulations Other
measures
Amended
since last
year
(a) Development, production, stockpiling,
acquisition or retention of microbial or other
biological agents, or toxins, weapons, equipment and
means of delivery specified in Article I
YES/NO YES/NO YES/NO YES/NO
(b) Exports of micro-organisms and toxins YES/NO YES/NO YES/NO YES/NO
(c) Imports of micro-organisms and toxins YES/NO YES/NO YES/NO YES/NO
(d) Biosafety measures YES/NO YES/NO YES/NO YES/NO
(e) Biosecurity measures YES/NO YES/NO YES/NO YES/NO
(f) Codes of conduct addressing the “dual use”
problemYES/NO
(g) National point of contact YES/NO
CONFIDENCE-BUILDING MEASURE „E“ (2)
(h) Indicate areas in which assistance for implementation
of regulations and/or other measures would be welcomed,
including a point of contact to whom offers might be
directed
(i) Indicate areas in which assistance for implementation
of regulations and/or other measures could be provided,
including a point of contact from whom such assistance
may be requested
CONFIDENCE-BUILDING MEASURE „G"
Declaration of vaccine production facilities
To further increase the transparency of biological research and development related to
the Convention and to broaden scientific and technical knowledge as agreed in Article X,
each State party will declare all facilities, both governmental and non-governmental,
within its territory or under its jurisdiction or control anywhere, producing vaccines licensed
by a central government department or agency of the State party for the protection
of humans and/or animals. Information shall be provided on Forms G (i) and G (ii) attached.
Form G (i)
Declaration of vaccine production facilities for human vaccines
1. Name of facility:
2. Location (mailing address):
3. General description of the types of diseases covered:
Form G (ii)
Declaration of production facilities for animal vaccines
1. Name of facility:
2. Location (mailing address):
3. General description of the types of diseases covered:
CONFIDENCE-BUILDING MEASURE „0"
Measure Nothing to
declare
Nothing new
to declare
Indicate year of
last declaration
if “Nothing new
to declare”
Form A, part 1
Form A, part 2 (i)
The way forward
Draft CBM working paper available on e-mail
platform
► Draft CBM working paper on ISU website –
Think zone
► Discussion of draft CBM working paper in
planned workshops for preparing Seventh
Review Conference
